Physician-scientist Juanma Schvartzman is a firm believer that his curiosity-driven research on cell metabolism and its influence on cell identity will offer clues for better cancer treatments.
Combining a diabetes drug with a cancer drug not only kills aggressive bladder cancer cells in mice, but also turns remaining malignant cells into a more benign state.
Lewis Silverman, the new director of pediatric hematology, oncology, and stem cell transplantation, is working to minimize the aftereffects of treatment to ensure the highest quality cure possible.